Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableEnded earlyNCT00665444
What this trial is testing

Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder

Who this might be right for
Bipolar DisorderMetabolic Syndrome
University of Pittsburgh 3
Not applicableUnknownNCT00569764
What this trial is testing

Effect on Metabolic Parameters of Abilify in SPR

Who this might be right for
SchizophreniaMetabolic Syndrome
Seoul National Hospital 100
Large-scale testing (Phase 3)Study completedNCT00194012
What this trial is testing

Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder

Who this might be right for
Bipolar Disorder
University Hospitals Cleveland Medical Center 62
Post-approval studies (Phase 4)Study completedNCT03568500
What this trial is testing

A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

Who this might be right for
SchizophreniaSchizoaffective DisorderFirst Episode Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 44
Post-approval studies (Phase 4)Study completedNCT00205660
What this trial is testing

Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

Who this might be right for
SchizophreniaType 2 Diabetes Mellitus
Washington University School of Medicine 51
Early research (Phase 1)Looking for participantsNCT04789915
What this trial is testing

Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis

Who this might be right for
PsychosisNegative Symptoms With Primary Psychotic Disorder
Bjorn H. Ebdrup 46
Not applicableStudy completedNCT03358277
What this trial is testing

Aripiprazole Added on for DMDD in Youths With ADHD

Who this might be right for
Disruptive Mood Dysregulation Disorder
Tri-Service General Hospital (TSGH) 58
Post-approval studies (Phase 4)Study completedNCT01411930
What this trial is testing

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

Who this might be right for
Diabetes
Veterans Medical Research Foundation 15
Early research (Phase 1)Study completedNCT00780702
What this trial is testing

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

Who this might be right for
Cocaine DependenceCocaine-Related DisordersOpioid-Related Disorders
National Institute on Drug Abuse (NIDA) 41
Testing effectiveness (Phase 2)Study completedNCT00202007
What this trial is testing

Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 240